Walleye Trading
AXSM icon

Walleye Trading’s Axsome Therapeutics AXSM Stock Holding History

Walleye Trading’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-600
Closed -$110K – 4127
2025
Q4 		$110K Hold
600
– – ﹤0.01% 3697
2025
Q3 		$72.9K Sell
600
-6,000
-91% -$676K ﹤0.01% 3840
2025
Q2 		$689K Buy
6,600
+3,200
+94% +$339K ﹤0.01% 2442
2025
Q1 		$397K Buy
+3,400
New +$387K ﹤0.01% 2669
2024
Q4 		– Sell
-1,000
Closed -$89.9K – 4241
2024
Q3 		$89.9K Sell
1,000
-500
-33% -$43.6K ﹤0.01% 3350
2024
Q2 		$121K Sell
1,500
-700
-32% -$51.8K ﹤0.01% 3314
2024
Q1 		$176K Sell
2,200
-1,200
-35% -$101K ﹤0.01% 3494
2023
Q4 		$271K Sell
3,400
-2,800
-45% -$187K ﹤0.01% 3568
2023
Q3 		$433K Buy
6,200
+2,000
+48% +$150K ﹤0.01% 3064
2023
Q2 		$302K Buy
4,200
+1,900
+83% +$140K ﹤0.01% 3143
2023
Q1 		$142K Sell
2,300
-12,400
-84% -$815K ﹤0.01% 3707
2022
Q4 		$1.13M Buy
14,700
+13,800
+1,533% +$825K ﹤0.01% 2121
2022
Q3 		$40K Sell
900
-900
-50% -$45K ﹤0.01% 4296
2022
Q2 		$69K Buy
1,800
+1,200
+200% +$38K ﹤0.01% 4226
2022
Q1 		$25K Buy
600
+100
+20% +$3.1K ﹤0.01% 4705
2021
Q4 		$19K Sell
500
-1,500
-75% -$55.2K ﹤0.01% 4942
2021
Q3 		$66K Sell
2,000
-5,600
-74% -$218K ﹤0.01% 4547
2021
Q2 		$513K Buy
7,600
+4,900
+181% +$294K ﹤0.01% 2885
2021
Q1 		$153K Sell
2,700
-5,900
-69% -$415K ﹤0.01% 3849
2020
Q4 		$701K Buy
8,600
+3,500
+69% +$262K ﹤0.01% 2357
2020
Q3 		$363K Sell
5,100
-4,400
-46% -$343K ﹤0.01% 2518
2020
Q2 		$782K Buy
9,500
+9,400
+9,400% +$723K 0.01% 1877
2020
Q1 		$6K Hold
100
– – ﹤0.01% 3778
2019
Q4 		$10K Buy
+100
New +$4.04K ﹤0.01% 4060

Other funds holding AXSM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Walleye Trading's AXSM Position: Q1 2026 in Review

Walleye Trading sold out of Axsome Therapeutics (AXSM) in Q1 2026, closing a stake of 1,219 shares — an estimated $223K sold.

Walleye Trading first reported a position in AXSM in Q1 2018 and held it in 15 quarters. The position peaked at $5.73M in Q4 2019. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

  • Walleye Trading reported no remaining Axsome Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Walleye Trading sold 1,219 Axsome Therapeutics shares in Q1 2026, an estimated $223K.
  • Walleye Trading first reported a position in Axsome Therapeutics in Q1 2018 and held it in 15 quarters.
  • Walleye Trading's Axsome Therapeutics position peaked at $5.73M in Q4 2019.
  • 409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.